These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 30664724)

  • 21. Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial.
    Mittelman M; Platzbecker U; Afanasyev B; Grosicki S; Wong RSM; Anagnostopoulos A; Brenner B; Denzlinger C; Rossi G; Nagler A; Garcia-Delgado R; Portella MSO; Zhu Z; Selleslag D
    Lancet Haematol; 2018 Jan; 5(1):e34-e43. PubMed ID: 29241762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eltrombopag as first-line treatment for thrombocytopenia among paediatric patients after allogeneic haematopoietic stem cell transplantation.
    Qiu KY; Liao XY; Huang K; Wu RH; Xu HG; Xu LH; Li Y; Weng WJ; Zhou DH; Fang JP
    Br J Clin Pharmacol; 2021 Apr; 87(4):2023-2031. PubMed ID: 33080064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eltrombopag use in a patient with Wiskott-Aldrich syndrome.
    Gabelli M; Marzollo A; Notarangelo LD; Basso G; Putti MC
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28643468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eltrombopag for post-transplant cytopenias due to poor graft function.
    Marotta S; Marano L; Ricci P; Cacace F; Frieri C; Simeone L; Trastulli F; Vitiello S; Cardano F; Pane F; Risitano AM
    Bone Marrow Transplant; 2019 Aug; 54(8):1346-1353. PubMed ID: 30679824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia.
    Lu Y; Sun RJ; Zhao YL; Xiong M; Cao XY; Zhang JP; Wei ZJ; Zhou JR; Liu DY; Lu DP
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1881-1887. PubMed ID: 29772350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eltrombopag treatment promotes platelet recovery and reduces platelet transfusion for patients with post-transplantation thrombocytopenia.
    Gao F; Zhou X; Shi J; Luo Y; Tan Y; Fu H; Lai X; Yu J; Huang H; Zhao Y
    Ann Hematol; 2020 Nov; 99(11):2679-2687. PubMed ID: 32519094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eltrombopag for Treating Thrombocytopenia after Allogeneic Stem Cell Transplantation.
    Yuan C; Boyd AM; Nelson J; Patel RD; Varela JC; Goldstein SC; Ahmad S; Zhu X; Mori S
    Biol Blood Marrow Transplant; 2019 Jul; 25(7):1320-1324. PubMed ID: 30710685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and cost analysis of eltrombopag in thrombocytopenia and poor graft function post allogeneic hematopoietic cell transplantation.
    Nampoothiri RV; Ho L; McEwan C; Pasic I; Lam W; Law AD; Michelis FV; Thyagu S; Kim DDH; Gerbitz A; Viswabandya A; Lipton JH; Mattsson J; Kumar R
    Bone Marrow Transplant; 2021 Oct; 56(10):2471-2476. PubMed ID: 34108675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial.
    Platzbecker U; Wong RS; Verma A; Abboud C; Araujo S; Chiou TJ; Feigert J; Yeh SP; Götze K; Gorin NC; Greenberg P; Kambhampati S; Kim YJ; Lee JH; Lyons R; Ruggeri M; Santini V; Cheng G; Jang JH; Chen CY; Johnson B; Bennett J; Mannino F; Kamel YM; Stone N; Dougherty S; Chan G; Giagounidis A
    Lancet Haematol; 2015 Oct; 2(10):e417-26. PubMed ID: 26686043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Eltrombopag for thrombocytopenia in 24 children after hematopoietic stem cell transplantation].
    Liu S; Que LP; Huang K; Fang JP; Wang KM; Zhan LP; Liu DD; Xu HG
    Zhonghua Er Ke Za Zhi; 2021 Apr; 59(4):311-315. PubMed ID: 33775051
    [No Abstract]   [Full Text] [Related]  

  • 31. Oral eltrombopag versus subcutaneous recombinant human thrombopoietin for promoting platelet engraftment after allogeneic stem cell transplantation: A prospective, non-inferiority, randomized controlled trial.
    Wen B; Zhang X; Chen S; Fan J; Yang S; Cai Y; Wang P; Zhang Q; Gu Q; Du X
    Hematol Oncol; 2022 Oct; 40(4):777-786. PubMed ID: 35554955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy.
    Afdhal NH; Dusheiko GM; Giannini EG; Chen PJ; Han KH; Mohsin A; Rodriguez-Torres M; Rugina S; Bakulin I; Lawitz E; Shiffman ML; Tayyab GU; Poordad F; Kamel YM; Brainsky A; Geib J; Vasey SY; Patwardhan R; Campbell FM; Theodore D
    Gastroenterology; 2014 Feb; 146(2):442-52.e1. PubMed ID: 24126097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful Use of Eltrombopag in a Child With Hurler Syndrome After Haploidentical Hematopoietic Stem Cell Transplantation.
    Naithani R; Sachdev M; Uttam R
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):163-4. PubMed ID: 26491856
    [No Abstract]   [Full Text] [Related]  

  • 34. Eltrombopag dose predictors in thrombocytopenic subjects with hepatitis C virus infection.
    Saleh MI; Obeidat AR; Anter HA; Khanfar AA
    Clin Exp Pharmacol Physiol; 2015 Oct; 42(10):1030-5. PubMed ID: 26173631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of eltrombopag, a thrombopoietin receptor agonist, in post-transplantation thrombocytopenia.
    Reid R; Bennett JM; Becker M; Chen Y; Milner L; Phillips GL; Liesveld J
    Am J Hematol; 2012 Jul; 87(7):743-5. PubMed ID: 22573520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eltrombopag Therapy in Children With Rare Disorders Associated With Thrombocytopenia.
    Frączkiewicz J; Sęga-Pondel D; Kazanowska B; Ussowicz M
    J Pediatr Hematol Oncol; 2020 Mar; 42(2):113-117. PubMed ID: 31205222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Successful treatment of post-allogeneic hematopoietic transplant immune thrombocytopenia with eltrombopag].
    Narita Y; Uchiyama T; Mizumoto C; Takeoka T; Tomo K; Tsuji M; Ohno T
    Rinsho Ketsueki; 2018; 59(11):2418-2422. PubMed ID: 30531136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial.
    Arnold DM; Heddle NM; Cook RJ; Hsia C; Blostein M; Jamula E; Sholzberg M; Lin Y; Kassis J; Larratt L; Tinmouth A; Amini S; Schipperus M; Lim W; Vishnu P; Warner M; Carruthers J; Li N; Lane S; Kelton JG
    Lancet Haematol; 2020 Sep; 7(9):e640-e648. PubMed ID: 32853584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haploidentical hematopoietic stem cell transplantation as a first-line treatment for paediatric severe aplastic anemia: a single-center research.
    Yuan M; Jia C; Ma J; Zhang M; Zhu G; Wang B; Zheng J; Qin M; Wu R; Li S
    Int J Med Sci; 2024; 21(6):1027-1036. PubMed ID: 38774762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eltrombopag for the treatment of poor graft function following allogeneic stem cell transplant: a retrospective multicenter study.
    Giammarco S; Sica S; Chiusolo P; Laurenti L; Sorá F; Martino M; Metafuni E; Busca A; Risitano A; Vallejo C; Bacigalupo A
    Int J Hematol; 2021 Aug; 114(2):228-234. PubMed ID: 33886103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.